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Abstract
Immunosenescence predisposes the elderly to infectious and autoimmune diseases and impairs the response to
vaccination. We recently demonstrated that ageing also impedes development of transplantation tolerance. Unlike
their young counterparts (8-12 weeks of age) aged male recipients (greater than 12 months of age) transplanted with
a  full  MHC-mismatched  heart  are  resistant  to  tolerance  mediated  by  anti-CD45RB  antibody.  Surprisingly,  either
chemical or surgical castration restored tolerance induction to levels observed using young recipients. Based on the
strong impact of endocrine modulation on transplant tolerance, we explored the impact of ageing and castration on
the immune system. Here we report a significant increase in the percentage of T cells that produce interferon-γ (IFN-
γ)  in  aged  male  versus  young  male  animals  and  that  the  overall  increase  in  IFN-γ  production  was  due  to  an
expansion of IFN-γ-producing memory T cells in aged animals. In contrast to IFN-γ production, we did not observe
differences in IL-10 expression in young versus old male mice. We hypothesized that endocrine modulation would
diminish the elevated levels of IFN-γ production in aged recipients, however, we observed no significant reduction in
the percentage of IFN-γ+ T cells upon castration. Furthermore, we neutralized interferon-γ by antibody and did not
observe an effect on graft survival. We conclude that while elevated levels of interferon-γ serves as a marker of
tolerance resistance in aged mice, other as yet to be identified factors are responsible for its cause. Defining these
factors may be relevant to design of tolerogenic strategies for aged recipients.
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Introduction
The  elderly  are  the  fastest  growing  segment  of  the
population with end-stage organ disorders, and their numbers
on the transplant waiting list continue to rise [1–4]. By 2020, for
the first time in human history, the number of people older than
65 will outnumber the number of children under 5 [5]. Induction
of  durable  donor  specific  tolerance  could  allow  successful
transplantation  without  the  morbidity  of  immunosuppression
[6,7].  To  be  broadly  applicable,  it  will  need  to  succeed  in
recipients  of  all  ages,  yet  clinical  and  laboratory  transplant
tolerance induction protocols almost exclusively rely on young
recipients. Furthermore, the majority of basic science research
in tolerance takes place in young animals. Thus, in order for
tolerance  to  become  a  reality  for  the  majority  of  transplant
patients, it is essential to understand the effects of ageing on
transplant tolerance.
Due to a decline in immune function, the elderly are more
susceptible  to  infectious  disease  and  malignancy,  while
exhibiting an impaired response to vaccination [8–10]. At the
cellular  level,  ageing  is  associated  with  a  decrease  in  the
number  of  naive  lymphocytes,  a  decreased  proliferation  of
CD4+CD25-  T  cells,  and  a  decreased  response  to  mixed
lymphocyte reaction [11,12]. This would suggest that tolerance
might  be  more  easily  achievable  in  the  elderly,  but
immunosenescence  is  also  accompanied  with  increased
autoimmune disease and cardiovascular disease, in which an
over-reactive  immune  response  is  thought  to  play  a  role
perhaps  suggesting  some  loss  of  regulation  [13–15].  In
addition, an increase in the ratio of memory to naive T cells
(Tnaive)  is  seen  in  observed  in  older  humans  and  mice
PLOS ONE | www.plosone.org 1 December 2013 | Volume 8 | Issue 12 | e82856[16],and memory T cells (Tmem) have a decreased threshold
of activation and are resistant to costimulatory blockade [17].
IFN-γ  production  by  memory  T  cells  is  also  associated  with
acute renal rejection [18,19].
Donor age, recipient age, and donor-recipient age difference
all influence graft survival [20–25]. In a study of nearly 49,000
kidney  transplant  recipients,  graft  loss  associated  with  acute
rejection  episodes  was  considerably  higher  in  elderly
recipients; five-year death censored kidney graft survival was
59.9%  for  recipients  over  age  65  versus  82%  for  recipients
under age 35 [25]. This suggests that the elderly may require
more  intense  conditioning  protocols  for  tolerance  induction,
which  is  complicated  by  the  fact  that  immunosuppressive
therapy  also  carries  higher  morbidity  for  elderly  patients
[24,26].
We  have  observed  that  a  short  course  of  anti-CD45RB
reliably induces stable, robust tolerance to various allogeneic
grafts  in  young  mice  but  never  in  aged  mice  [27–29].  In  a
cardiac  transplant  model,  over  half  of  heart  grafts  survived
long-term in young male recipients, while in old male recipients,
all  grafts  were  rejected  quickly.  Recently,  T  cell  interferon-γ
production  has  been  reported  to  play  a  key  role  in  age-
dependent tolerance resistance [30]. We hypothesized that the
increased  proportion  of  IFN-γ  producing  memory  T  cells
impairs tolerance induction in aged mice, and that castration
returns IFN-γ production to normal levels.
Materials and Methods
Mice
Male  C3H/HeJ  and  C57BL/6,  aged  8  to  10  weeks,  were
purchased from Jackson Labs (Bar Harbor, Maine). All mice
were  housed  under  specific  pathogen-free  conditions  in
approved plastic cages in the animal facility of Massachusetts
General  Hospital.  Mice  were  randomized  to  control  and
experimental  groups.  Mice  were  housed  4  per  cage  under
standard  conditions  at  constant  temperature,  humidity,  and
light/dark cycles, and provided with food and water ad libitum.
All  protocols  detailed  below  were  performed  following  the
principles of laboratory animal care and approved by the MGH
Institutional Animal Care and Use Committee (#2007N000023).
The protocol conforms to the USDA Animal Welfare Act, PHS
Policy on Humane Care and Use of Laboratory Animals, the
“ILAR Guide for the Care and Use of Laboratory Animals” and
other applicable laws and regulations. All efforts were made to
minimize suffering.
Transplantation
Skin  grafts  were  transplanted  to  mice  according  to  the
technique  of  Billingham  and  Medawar  [31]  as  previously
described. 100 ug of anti-CD45RB (HB220) and 250 ug of anti-
CD40L (MR1) was administered on days 0, 1, 3, 5, and 7 post-
transplant; both antibodies were from BioXCell (Lebanon, NH).
Anti-interferon-γ (XMG1.2, BioXCell) was administered on days
0, 1, 3, 5, and 7 post-transplant either at 200 ug or 600 ug per
dose.  Euthanasia  was  by  cervical  dislocation  under  Avertin
anesthesia (125-250 mg/kg IP).
For  pain  management,  animals  designated  for  transplant
were  administered  pre-emptive  analgesia  for  post-operative
pain control. The first dose of analgesic was given 30 minutes
prior to the initiation of the surgical procedure. Buprenex 0.05
to 0.1 mg/kg sc q 8-12 hrs was administered for the first 3 days
post-procedure. In addition, the animals were kept warm and
monitored for one hour post-transplant, then at least daily for
the first week to assess the general health status of the mouse
as well as look for signs of distress. After the first week, the
animals were examined 2-3 times per week until graft rejection.
A skin graft is not a life-threatening procedure, and transplant
recipients recover quickly and generally do not die. Any animal
in the study that exhibited lethargy, weight loss, ruffled fur, an
abnormal  appearance,  or  any  other  serious  health  condition
was euthanized humanely.
Cell preparation and flow cytometry
Single  cell  suspensions  were  generated  from  spleens  and
peripheral lymph nodes by passage through a 70μM nylon cell
strainer  followed  by  RBC  lysis  buffer  (Sigma-Aldrich).  Cells
were stimulated in Complete Medium (RPMI 1640 containing
10%  fetal  bovine  serum  (HyClone  FetalClone  III,  Thermo
Scientific),  50  μM  2-mercaptoethanol  (ACROS  Organics),  1
mM sodium pyruvate, NEAA, 2 mM L-glutamine, 100 IU mL-1
Penicillin,  and  100  μg  mL-1  Streptomycin,  all  from  MP
Biomedicals) with PMA (50 ng mL-1, Sigma), ionomycin (1 μg
mL-1, Sigma), monensin (GolgiStop; 4 μg mL-1, BD), and either
with or without LPS (10 μg mL-1 Escherichia coli serotype 0111:
B4, Sigma) in 6 well tissue culture treated plates for 5 hours in
a 37° C / 5% CO2 incubator.
Cells  were  surface  stained  at  4°C  in  FACS  buffer  (PBS
containing 2% FBS and 0.1% sodium azide) in 96 well plates,
with  2  x  106  cells  per  well.  Fc  receptors  were  blocked  with
purified anti-Mouse CD16/CD32 (2.4G2, BD Pharmingen) prior
to cell surface staining. Fluorescently labeled mAbs were used
for  the  following  markers:  CD4  (GK1.5,  Biolegend),  B220
(RA3-6B2,  Biolegend),  CD8  (53-6.7,  eBioscience),  CD62L
(MEL-14, eBioscience), and CD44 (IM7, BD).
Intracellular  staining  was  performed  using  the  Intracellular
Staining  Buffer  Set  (eBioscience)  according  to  the
manufacturer’s  instructions.  Cells  were  stained  with
fluorescently  labeled  mAbs  or  non-specific  isotypes  for  the
following markers: IFN-γ (XMG1.2), IL-10 (JES5-16E3), all from
eBioscience. Samples were run on a LSRII flow cytometer (BD
Biosciences) and analyzed using FlowJo software (Tree Star,
Inc.).
Statistical analysis
Data  were  analyzed  using  GraphPad  Prism  (version  5,
GraphPad  Software).  Graft  survival  between  experimental
groups was compared using Kaplan-Meier survival curves and
Wilcoxon  statistics.  Other  differences  between  experimental
groups were analyzed using the Student’s t test. P values less
than 0.05 were considered statistically significant.
IFN-g Levels in Transplant Tolerance Resistance
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Ageing impairs tolerance induction to skin grafts
As previously reported, aged recipients are resistant to anti-
CD45RB  antibody-mediated  transplant  tolerance  to  heart
allografts.  In  young  anti-CD45RB-treated  C57BL/6  recipients,
roughly 60% of C3H/H3J heart grafts survive long-term (>100
days), while C3H/HeJ heart grafts are rapidly rejected in aged
recipients (greater than one year-old [29]) receiving the same
antibody  treatment.  Using  the  same  strain  combination,  we
examined  whether  age-dependent  tolerance  resistance  could
also be extended to skin grafts. Both untreated young and old
C57BL/6 skin graft recipients reject C3H/HeJ skin grafts at the
same tempo (Figure 1). C3H/HeJ donors are less than three
months old. When treated with anti-CD45RB plus anti-CD40L,
50% of young C57BL/6 recipients grafted with C3H/HeJ skin
survive greater than 80 days, however, median survival time for
antibody-treated  aged  recipients  is  16.5  days  (Figure  1).
Neither  antibody  extends  graft  survival  in  young  recipients
(data not shown). Thus, as with heart grafts, aged recipients
are also resistant to prolongation of skin graft survival.
Elevated production of IFN-γ in aged animals
To  understand  the  basis  for  this  resistance  to  tolerance
induction  in  old  mice,  we  examined  whether  their  T  cell
cytokine profile differed from that of T cells from young mice.
We  compared  interferon-γ  production  by  CD4+  and  CD8+  T
cells  in  spleen  and  lymph  node  (LNC)  of  young  versus  old
mice. IFN-γ production by memory T cells has correlated with
acute renal rejection [18,19], and we hypothesized that IFN-γ
production  in  aged  animals  would  be  higher  than  in  young.
Overall, the percentages of lymphocytes comprising the spleen
were not significantly altered, but we did observe a decrease in
the  percentage  of  CD4+  T  cells  in  aged  naive  male  mice
(Figure  S1).  In  naive  male  animals,  a  significantly  higher
percentage  of  CD4+  and  CD8+  T  cells  from  aged  mice
produced IFN-γ than from young mice (Figure 2) suggesting a
possible mechanism of tolerance resistance in aged recipients.
Memory T cell expansion results in elevated IFN-γ
production by aged animals
We next examined which subset of T cells - Tnaive or Tmem
-  produced  the  elevated  levels  of  IFN-γ.  Tmem  have  a
decreased  threshold  of  activation  and  are  resistant  to
costimulatory blockade [17], thus, an increased percentage of
Tmem  would  play  a  significant  contribution  to  transplant
tolerance resistance. Spleens from naive aged mice, despite
being  housed  in  germ-free  conditions,  exhibited  a  significant
increase in the percentage of both CD4+ and CD8+ memory T
cells (Figure 3A) compared to naive young mice. Lymph nodes
were not examined.
We next examined whether the frequency of IFN-γ-producing
Tmem  or  Tnaive  was  higher  in  aged  animals  versus  naive
animals.  By  gating  on  naive  CD4+  and  CD8+  T  cells  in
unchallenged  young  and  old  animals  we  found  a  higher
percentage  of  naive  T  cells  produce  IFN-γ  in  aged  animals
compared to young animals, yet overall fewer than 2% of the
naive T cell populations produced IFN-γ (Figure 3B). When we
examined IFN-γ production by memory T cells, we observed a
significantly  higher  percentage  of  IFN-γ+  memory  CD4+  and
CD8+ T cells in aged mice compared to those in young mice.
These data suggest that IFN-γ production by Tmem may be
involved in age-dependent transplant tolerance resistance.
Next  we  examined  the  impact  of  transplantation  on  the
percentage of Tmem. We hypothesized that memory T cells in
transplanted  aged  recipients  would  exhibit  more  robust
expansion than memory T cells in young recipients. Male mice
received a skin graft, and spleens were analyzed at two weeks
post-transplantation. In young recipients, there is an increase in
both  CD4+  and  CD8+  Tmem  after  skin  graft  transplantation
which  was  not  statistically  significant.  In  contrast,  in  aged
recipients,  there  is  a  statistically  significant  increase  in  both
CD4+ and CD8+ Tmem after transplantation (Figure 3A). Most
importantly, IFN-γ production by CD4+ T cells of transplanted
aged  recipients  rises  with  antibody  treatment,  while  young
recipients' CD4+IFN-γ production decreases back to baseline
levels  (Figure  2).  These  data  suggest  that  the  increase  in
tolerance resistance in aged mice may be related to the failure
of antibody treatment to control IFN-γ production by Tmem.
Figure 1.  In contrast to young recipients, aged recipients are resistant to transplant tolerance induction.  Young C57BL/6
recipients (less than 3-months of age) and aged C57BL/6 recipients (over 12-months of age) reject C3H/HeJ skin graft at same
tempo. When treated with anti-CD45RB and anti-CD154 antibodies, 50% of skin grafts survive over 80 days. In contrast, antibody-
treated aged recipients reject quickly (aged MST = 16.5 days versus young MST = 87.5 days, p>0.001**).
doi: 10.1371/journal.pone.0082856.g001
IFN-g Levels in Transplant Tolerance Resistance
PLOS ONE | www.plosone.org 3 December 2013 | Volume 8 | Issue 12 | e82856We  next  examined  whether  IL-10  levels  were  altered  in
young male mice versus aged male mice. IL-10 is also a critical
cytokine in Th1/Th2 development, and elevated levels of IL-10
and  Th2  cytokines  correlates  with  prolonged  graft  survival
[32–34].  We  hypothesized  that  IL-10  production  would  be
significantly lower in aged mice as a result of elevated IFN-γ
Figure 2.  A higher percentage of both CD4 and CD8 T cells from aged animals produce IFN-γ relative to those from young
animals.  Spleen and lymph node (LNC) from naive animals, grafted animals, and grafted, anti-CD45RB / anti-CD154-treated
animals were examined 14 days after transplant, p<0.05*. Representative FACS plots are shown, bottom. 2 to 3 animals were
examined independently in each group.
doi: 10.1371/journal.pone.0082856.g002
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were unchanged in young male versus aged male mice (Figure
4).
Castration does not significantly modulate percentage
of IFN-γ-producing T cells
We  have  previously  demonstrated  that  castration  restores
tolerance  to  aged,  tolerance-resistant  recipients  [29].  We
examined  whether  modulation  of  IFN-γ  production  correlated
with the restoration of tolerance. Grafted and non-grafted aged
animals were castrated, and spleen and draining lymph node
were  examined  two  weeks  post-transplant.  Castration  was
performed 30 days prior to transplant. Grafted C57BL/6 mice
were transplanted with C3H skin grafts and treated with anti-
CD40L / anti-CD45RB antibodies for one week. In the absence
of a skin graft, castration did reduce the percentage of IFN-γ+ T
cells  in  the  draining  lymph  node,  however,  overall,  and
especially  in  the  transplant  setting,  there  was  no  significant
difference in castrated versus non-castrated groups (Figure 5).
When  we  specifically  examining  activated  CD4+  CD44+  T
cells, still we did not observe any significant difference between
castrated  and  non-castrated  groups  (data  not  shown).  Thus,
these  data  suggest  the  elevated  levels  of  IFN-γ-producing  T
cells  may  not  be  the  cause  of  tolerance  resistance  in  aged
transplant recipients.
Neutralization of IFN-γ does not restore antibody-
mediated tolerance induction
To further define the role of increased IFN-γ secretion, we
neutralized this cytokine in the aged animals by anti-interferon-
γ neutralizing antibody. We used two different doses of anti-
IFN-γ antibody (clone XMG1.2) to see if we could prolong graft
survival  as  well  as  to  see  if  there  was  a  dosage  effect.  We
utilized a previously reported regimen [35], and the high dose
of  anti-IFN-γ  antibody  was  sufficient  to  accelerate  graft
rejection in a young recipient (Figure S2). C57BL/6 mice were
transplanted with C3H skin grafts and treated with anti-CD40L /
anti-CD45RB  antibodies  with  or  without  co-injection  of  anti-
Figure 3.  Memory T, not naive T, exhibit elevated production of IFN-γ, in young and old animals.  (A) CD4 and CD8 memory
T cells expand in aged animals. Young and aged animals, with and without skin graft, were examined for memory T cells 14 days
post-transplant. At least two to three animals were examined independently per group. (B) Splenocytes were examined for CD4,
CD8, CD44, and IFN-γ expression. Tnaive cells were gated as CD4+ CD44low or CD8+ CD44low, while Tmem were gated as
CD44hi. The percentage of IFN-γ+ cells is plotted on the y-axis. At least two to three animals were examined independently per
group.
doi: 10.1371/journal.pone.0082856.g003
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observed  a  modest  prolongation  in  median  survival  time,
neither  dose  of  anti-interferon-γ  resulted  in  a  statistically
significant prolongation of skin graft survival.
Discussion
Our work and the work of others suggest that anti-CD45RB
treatment promotes the differentiation of Th2 cells and that this
Figure 4.  Young and aged animals exhibit similar levels of IL-10 production.  Spleen was examined for B220, CD4, CD8, and
IL-10. Y-axis indicates percentage of B220+, CD4+, or CD8+ cells that were IL-10+. At least two to three animals were examined
independently per group.
doi: 10.1371/journal.pone.0082856.g004
Figure 5.  Castration does not significantly modulate levels of CD4+ IFN-γ+ and CD8+ IFN-γ+ T cells.  The effect of castration
was  examined  on  CD4+  and  CD8+  T  cells  from  spleen  and  lymph  node  of  ungrafted  and  grafted,  antibody-treated  animals.
Intracellular IFN-γ was examined two weeks after skin graft. Castration was performed 30 days before skin graft. In the absence of a
skin graft, castration reduced the % of IFN-γ+ T cells in the lymph node, however, overall, castration did not significantly affect the
percentages of IFN-γ production.
doi: 10.1371/journal.pone.0082856.g005
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Ab  [36].  Both  in  human  and  in  mouse,  ageing  has  been
demonstrated to be associated with a Th1-Th2 imbalance or a
diminished Th1-Th2 response [37], but the data are conflicting.
Aged  humans  have  been  reported  to  have  increased  Th1
[37,38],  decreased  Th1  [39],  increased  Th2  [37,38],  and
decreased Th2 [39]. Similar conflicting reports exist for mice,
but  such  tendencies  also  result  from  mouse  strain  and
experimental model differences [40–44]. The effects of ageing
on Th1/Th2 in an allograft response remain unclear. Our data
suggest  that  anti-CD45RB  antibody  maintains  low  levels  of
CD4  IFN-γ,  a  hallmark  Th1  cytokine,  in  grafted  young
recipients (Figure 2). However, upon antibody treatment, aged,
grafted animals produce significantly elevated levels of IFN-γ
relative to young, grafted, antibody treated animals (**p<0.01)
[19,30].  The  molecular  mechanism  underlying  this  elevated
IFN-γ expression remains unknown.
Interferon-γ  is  a  potent  inducer  of  cellular  immunity.  IFN-γ
may act directly to promote CD8 T cell responses, and it may
act  indirectly  by  skewing  CD4  Th  cells  towards  Th1  [45].  In
young recipients treated with anti-IFN-γ neutralizing antibody or
in  IFN-γ-deficient  recipients,  T  cell  costimulatory  blockade
resulted in decreased survival of allografts relative to wild-type
or untreated recipients. It was hypothesized that the absence of
interferon-γ resulted in uncontrolled proliferation of activated T
cells and subsequent accelerated rejection [46–48]. Interferon-
γ  may  also  act  on  the  graft  to  promote  its  survival  [49].
Consistent with this, we found that treatment of young C57BL/6
recipients  with  high  dose  anti-interferon-γ  resulted  in  more
rapid rejection.
Memory  CD8  T  cells  have  been  demonstrated  to  secrete
high  levels  of  IL-2  and  IFN-γ  in  both  mouse  and  in  human
[8,50,51].  Our  in  vitro  data  demonstrate  that  CD4  and  CD8
Tmem,  particularly  Tmem  of  aged  animals,  are  skewed
towards the production of IFN-γ. While both Tmem and Tnaive
may  differentiate  into  IFN-γ-producing  cells  in  vivo,  because
Tmem respond more quickly, they are likely to skew the overall
response. However, this high proportion of IFN-γ-producing T
cells  may  be  due  to  the  genetic  propensity  of  B6  to  skew
towards  Th1.  In  humans,  the  frequency  of  pre-transplant
Tmem, as measure by in vitro IFN-γ production, correlated with
risk of acute renal allograft rejection [18,19].
Despite  housing  in  a  germ-free  facility,  Tmem  in  aged
animals  are  likely  to  arise  either  through  heterologous
activation to an infectious agent or by bystander proliferation
[52–55].  Yet  since  these  Tmem  were  not  generated  by
sensitization to a previous transplant, it is surprising that these
cells  would  still  pose  such  a  formidable  barrier  to  transplant
tolerance [56]. The barrier is unlikely due simply to precursor
frequency  of  alloreactive  cells.  By  ELISpot,  Du  et  al.
demonstrated that the frequency of alloreactive cells in aged
mice pre-transplant was no greater than that in young animals.
Consistent  with  survival  data,  only  after  transplant  and  Ab
treatment was there a significant difference in the frequency of
alloreactive cells between young and aged animals.
We hypothesized that the increased IFN-γ production that we
observed  in  aged  mice  was  responsible  for  tolerance
resistance,  and  that  the  IFN-γ  production  might  in  turn  be
controlled by hormones. However, neither dose of anti-IFN-γ
prolonged  survival  in  aged  recipients  (Figure  6).  Most  skin
grafts  survived  beyond  15  days,  and  potentially  a  dosing
regimen in which anti-IFN-γ antibody was administered beyond
just  the  first  week  might  have  significantly  prolonged  graft
survival. Castration also had no effect on IFN-γ production in
aged mice, further suggesting IFN-γ alone does not mediate
tolerance resistance in aged mice, since castrated, aged mice
are no longer resistant to tolerance induction.
Based on our data and the work of others in the effects of
ageing on allograft transplantation outcome, we hypothesized
that  elevated  T  cell  interferon-γ  production  interfered  with
tolerance  induction.  However,  our  data  suggest  that  this
elevated IFN-γ production may not contribute to the tolerance
resistance observed with age, and perhaps interferon-γ is but a
marker of memory T cells which accumulate with age. Indeed,
IFN-γ  neutralization  did  prolong  graft  survival  in  aged  mice.
More  potent  therapies  involving  T  cell  depletion  and
costimulatory  blockade  of  ICOS  and  CD28/B7  have
demonstrated  significant  graft  survival  prolongation  in  young
recipients and should be examined in old recipients [57,58].
At  the  time  of  puberty  and  linked  with  an  increase  in  sex
steroid levels, the thymus atrophies [59,60]. This dramatic age-
Figure 6.  Neutralizing anti-interferon-γ antibody does not prolong graft survival in aged recipients.  C57BL/6 mice received
C3H skin grafts and were treated with anti-CD40L/anti-CD45RB antibodies with or without anti-interferon-γ antibodies (low dose at
200 ug or high dose at 600 ug). All antibodies were injected every other day for one week starting on the day of transplant.
doi: 10.1371/journal.pone.0082856.g006
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overall  thymocyte  cell  number,  and  the  absolute  number  of
single-positive CD4+ and CD8+ T cells that leave the thymus
[61,62].  Castration  has  been  demonstrated  to  restore  thymic
architecture,  improve  adaptive  immunity  in  both  sexes,  alter
lymphocyte  cytokine  profile,  and  in  some  cases,  reverse  the
Th1/Th2 differences [49,60,63–66]. We previously reported that
castration did restore thymic architecture. Our current finding
that neutralization of IFN-γ does not affect tolerance resistance
and that castration does not change IFN-γ levels would tend to
favor the importance of thymic rejuvenation and output in the
immunological alterations seen in aged mice.
Supporting Information
Figure S1.  The percentages of lymphocytes in the spleen
of an old mouse are not significantly different from that of
a  young  mouse.  Antibodies  to  CD4,  CD8,  and  B220  were
used  to  stain  splenocytes  of  young  and  old  mice,  and  cells
were  analyzed  by  flow  cytometry.  Percentage  of  CD4+  cells
decreased with age (20.7%+/-1.1 versus 14.5%+/-0.9, p<0.01).
Data  represent  two  independent  experiments  and  5  mice.
Young mice were 2 months of age, and old mice were over 12
months of age.
(TIF)
Figure  S2.    High  dose  anti-IFN-gamma  accelerates  graft
rejection.  Young  C57BL/6  mice  were  grafted  with  C3H/HeJ
skin and treated with anti-CD40L plus anti-CD45RB antibodies
with or without anti-IFN-gamma antibody. Recipients receiving
additional  IFN-gamma  antibody  exhibited  accelerated  graft
rejection.
(TIF)
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